Medco Health Valued At $6 Bil. Heading Into Aug. 19 Spin-Off
Executive Summary
Medco Health's initial valuation on Wall Street is in line with the price Merck paid to acquire the pharmacy benefit management company in 1993
You may also be interested in...
Merck Succession Plan: Board Wants “Internal” Successor, CEO Says
Merck is focusing on internal candidates to succeed CEO Ray Gilmartin when he retires in 2006, Gilmartin told analysts during Merck's annual business briefing in Whitehouse Station, N.J. Dec. 9
Merck Succession Plan: Board Wants “Internal” Successor, CEO Says
Merck is focusing on internal candidates to succeed CEO Ray Gilmartin when he retires in 2006, Gilmartin told analysts during Merck's annual business briefing in Whitehouse Station, N.J. Dec. 9
Medco Eyeing “Vigorous” Public Relations Defense To False Claims Act Suit
Medco is planning an aggressive public relations defense to coincide with its legal fight against Philadelphia's U.S. Attorney